Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Coronavirus Vaccine Efforts Key to Vaxart (VXRT) Q2 Earnings
12:40pm, Tuesday, 04'th Aug 2020
Vaxart (VXRT) has been working on developing a coronavirus vaccine. Increased clinical activity is expected to have increased expenses.
San Francisco, California--(Newsfile Corp. - August 3, 2020) - Hagens Berman urges Vaxart, Inc.
LOS ANGELES--(BUSINESS WIRE)---- $VXRT #VXRT--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Vaxart, Inc.
2 Risky Coronavirus Vaccine Stocks That Could Make You Filthy Rich
10:00am, Monday, 03'rd Aug 2020
Heat Biologics and Vaxart could have a lot more room to run.
3 Small-Cap Coronavirus Stocks That Could Skyrocket
07:04am, Sunday, 02'nd Aug 2020
The potential rewards are high. But so are the risks.
San Francisco, California--(Newsfile Corp. - July 31, 2020) - Hagens Berman urges Vaxart, Inc.
LOS ANGELES--(BUSINESS WIRE)---- $VXRT #VXRT--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Vaxart, Inc.
Vaxart (VXRT) to Report Q2 Earnings: What's in the Cards?
12:01pm, Wednesday, 29'th Jul 2020
Vaxart (VXRT) has been actively engaged in developing a coronavirus vaccine. Investors are likely to focus on progress of vaccine program on the Q2 earnings call.
ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against Vaxart, Inc. – VXRT
10:52am, Wednesday, 29'th Jul 2020
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces investigation of potential securities claims on behalf of shareholders of Vaxart, Inc. (NASDAQ: VXRT) resulting
SHAREHOLDER ALERT: Investigation of Vaxart Announced by Holzer & Holzer, LLC
10:05am, Tuesday, 28'th Jul 2020
ATLANTA--(BUSINESS WIRE)--Holzer & Holzer, LLC is investigating whether Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT) complied with federal securities laws.
New York, New York--(Newsfile Corp. - July 28, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vaxart, Inc.
This Coronavirus Stock Just Got More Attractive: Should You Buy?
09:10am, Tuesday, 28'th Jul 2020
This company has more than its COVID-19 programs going for it.
COVID-19 Vaccine Push Brings Hope: Stock & ETF Beneficiaries
08:00am, Tuesday, 28'th Jul 2020
There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.
Better Coronavirus Stock: Inovio vs. Vaxart
07:02am, Tuesday, 28'th Jul 2020
Two biotechs with promising COVID-19 vaccine candidates. But one is the clear winner right now.
Vaxart Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
07:03pm, Monday, 27'th Jul 2020
PHILADELPHIA, July 27, 2020 /PRNewswire/ -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Vaxart, Inc.
